Stay updated with breaking news from Mobile Opera. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mucosal melanoma — or melanoma in the mucous membranes — differs from cutaneous melanoma in its genesis, its treatment and its severity. Sometimes called a “hidden cancer,” mucosal melanoma is often more deadly than cutaneous melanoma. It is difficult to diagnose and often not found until the later stages, making treatment and survival more difficult.
Among children of all racial and ethnic groups, Hispanic/Latino, American Indian and Asian children developed chalazion at a higher rate, and those with meibomian gland disease or blepharitis were more likely to develop chalazia on multiple occasions.“Identifying those at higher risk of chalazion formation, recurrent chalazion and chalazion requiring surgery (often including general
CorneaGen issued product recalls for certain corneal and scleral patch grafts, according to press releases from the FDA.
United Therapeutics Corp. announced that the FDA has approved the Tyvaso dry powder inhaler for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease to improve exercise ability.Tyvaso DPI represents a new formulation and inhalation device for inhaled treprostinil and is the only dry powder inhaler approved by the FDA for use in PAH
First-line therapy with axicabtagene ciloleucel induced objective responses in 89% of patients with high-risk large B-cell lymphoma, according to phase 2 study results.An estimated 91% of patients treated with a single infusion of the chimeric antigen receptor T-cell therapy remained alive at 12 months, a primary analysis of the ZUMA-12 trial showed.